Abiopharma

🔍 Johansson Peter K. (Executive)

Company: CECO ENVIRONMENTAL CORP (CECO)

Report Date: 2026-08-15

Detailed Transactions and Holdings:

• Sold 2,914 shares of Common Stock at $79.59 per share (Direct)
  Date: 2026-08-15 | Code: F | equity_swap_involved: false | shares_owned_after: 37,832.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 47,247 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: H | shares_owned_after: 47,247.00 | Footnotes: F2, F3, F3
• Holds 30,000 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-15 | Code: H | shares_owned_after: 30,000.00 | Footnotes: F2, F4, F4

Footnotes:

• F1: Reflects shares withheld for net settlement to cover the tax liability for the vesting of restricted stock units.
• F2: Represents performance-based restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Company's stock.
• F3: Conversion of restricted stock units to the Company's common stock will occur on July 5, 2027 assuming the reporting person is still employed by the Company and if the shares of the Company's common stock have achieved certain stock price targets over the course of the performance period.
• F4: Conversion of restricted stock units to the Company's common stock will occur on September 12, 2029 assuming the reporting person is still employed by the Company and if the shares of the Company's common stock have achieved certain stock price targets over the course of the performance period.